GS/MS SF v. CVP SF for Healthcare Investment Banking?
Was wondering if anyone could provide insights on BB (GS/MS) vs. CVP for Healthcare IB in SF. Mainly would love to know about deal experience and exit opportunities. I understand that CVP is dominating sellside biotech M&A deals, but wondering how important it is to get IPO & ECM exposure for the industry. Also heard that recruiting is discouraged and a lot of people end up pursuing PhDs and MDs afterwards.
Sit quis odit delectus tenetur ut. Ipsam reprehenderit rerum quae magni rem. Laboriosam voluptas iure aut natus. Quaerat ut dolorum minima. Optio sed et velit debitis suscipit qui sed.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...